A Rare Case of Autoimmune Demyelinating Polyneuropathy and Hydrocephalus Secondary to Pembrolizumab

Pembrolizumab is a humanized monoclonal antibody that targets the programmed cell death 1 protein (PD-1) receptor and blocks the inhibitory checkpoint interaction between PD-1 and its ligands. This interaction leads to the upregulation of effector T-cells and downregulating regulatory T-cell product...

Descripción completa

Detalles Bibliográficos
Autores principales: Arora, Aakriti, Shere, Amar, Patel, Kunal, Gunawardhana, Nuwan, LiFuentes, Ericka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7180301/
https://www.ncbi.nlm.nih.gov/pubmed/32321302
http://dx.doi.org/10.1177/2324709620916358

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7180301/
https://www.ncbi.nlm.nih.gov/pubmed/32321302
http://dx.doi.org/10.1177/2324709620916358

Ejemplares similares